The content of this report will be updated with the latest scenarios based on the global COVID-19 Pandemic
Anesthesia is a medicine which is given to relieve pain and sensation during surgery. Drugs render a patient unresponsive and unconscious. United States Anesthesia Drugs Market is projected to reach US$ 5 Billion by the year 2024 owing to the increasing prevalence of cardiovascular cases, rising geriatric population and growing number of urgent surgeries in the United States. The different types of anesthesia are Local Anesthesia, General Inhalation Anesthesia and General Intravenous Anesthesia. Local Anesthesia and General Anesthesia are the two commonly used types of anesthesia. Local anesthesia is a condition when sensation within a specific body part in inhibited, where as general anesthesia results in loss of consciousness and sensation. Furthermore, the public and private health insurers’ consideration of adding anesthetic products in their reimbursement policy is expected to boost the US anesthesia drugs market in the recent years.
All Major Companies Losing their Market Share
In United States all established companies are losing their market share. Primarily because anesthesia drugs are mostly sold in generic form as it is available in the low cost. The companies studied in the report are Baxter International Inc, Endo International plc & AbbVie. Today, with the help of anesthesia medical facilities, performs various surgeries to treat patient’s deformities in the field of trauma, cardiovascular, gastrointestinal, urological, orthopedics, ophthalmology, neurology, oncology and cosmetics.
Renub Research report titled “United States Anesthesia Drugs Market, By Type [General Inhalation Anesthesia, General Intravenous Anesthesia (Propofol, Benzodiazepines Class, Fospropofol Disodium, Ketamine, Methohexital Sodium, Pentobarbital, Etomidate & Fentanyl) and Local Anesthesia (Articaine, Bupivacaine, Lidocaine, Mepivacaine & Prilocaine], Companies (Baxter International, Endo International plc, AbbVie & Others)” provides a complete analysis of United States Anesthesia Drugs Market.
By Type – General Intravenous Anesthesia leads the Market but Local Anesthesia Drugs is the Future
The report studies the market of the following Anesthesia Drugs segments: General Inhalation Anesthesia, General Intravenous Anesthesia can be further subdivided into (Propofol, Benzodiazepines Class, Fospropofol Disodium, Ketamine, Methohexital Sodium, Pentobarbital, Etomidate & Fentanyl), Among these anesthesia, Propofol and Benzodiazepines Class are the leading anesthesia drugs. Local Anesthesia is further segmented into (Articaine, Bupivacaine, Lidocaine, Mepivacaine & Prilocaine). Among these Articaine and Lidocaine have good market share.
Baxter International, Endo International plc, and AbbVie are some of the top companies operating in the United States Anesthesia Drugs Market; which has been studied thoroughly in the report.
This market research report provides a complete analysis of the United States Anesthesia Drugs Market and their projections for the upcoming years, Growth Drivers, Challenges, and Reimbursement policy.
By Type - United States Anesthesia Drugs Market
1. General Inhalation Anesthesia
2. General Intravenous Anesthesia
- Benzodiazepines Class
- Fospropofol Disodium
- Methohexital Sodium
3. Local Anesthesia
Key Players Sales - United States Anesthetic Drugs Market
1. Baxter International Inc
2. Endo International plc
This Report provides the answer of following Questions:
- What will be the United States Anesthesia Drugs Market by 2024?
- What will be the United States Local Anesthesia Drugs Market for the year 2024?
- What was the United States General Inhalation Anesthesia Drugs Market in 2017?
- Among General Inhalation, General Intravenous and Local Anesthesia; which one is driving the United States Anesthesia Drugs Market?
- What are the key driving forces for United States Anesthesia Drugs Market?
- What are the key challenges to United States Anesthesia Drugs Market?